title: [Isolated laringeal leishmaniasis and bone marrow culture (reply)].
authors.forename: M Dolores
authors.initials: MD
authors.lastname: Benítez
authors.forename: Consuelo
authors.initials: C
authors.lastname: Miranda
authors.forename: José M
authors.initials: JM
authors.lastname: Navarro
authors.forename: Fernando
authors.initials: F
authors.lastname: Morillas
authors.forename: Josefa
authors.initials: J
authors.lastname: Martín
authors.forename: Manuel
authors.initials: M
authors.lastname: de La Rosa
mesh_terms: D000328:Adult; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001706:Biopsy; D001853:Bone Marrow / Q000469:parasitology / Q000473:pathology*; D001854:Bone Marrow Cells / Q000469:parasitology; D002478:Cells, Cultured / Q000469:parasitology; D006801:Humans; D007818:Laryngeal Diseases / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology*; D007830:Larynx / Q000469:parasitology / Q000473:pathology; D018314:Leishmania infantum / Q000302:isolation & purification*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology*; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use
chemical_list: D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate